Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Latest Information Update: 26 Apr 2024
At a glance
- Drugs Low molecular weight heparin biosimilar-Shenzhen Techdow Pharmaceuticals/Valeo Pharma (Primary) ; Dalteparin sodium
- Indications Thrombophilia; Thrombosis
- Focus Therapeutic Use
- Acronyms PRIORITY
- 22 Apr 2024 Planned initiation date changed from 1 Feb 2024 to 1 Jun 2024.
- 04 Dec 2023 New trial record